Prostate Cancer Market Analysis Outlook, Industry Trends, Competitive Products Analysis, Technology, Top Players Growth Potentials and Future Investments
Market Research Future (MRFR) has launched a new release on
the Prostate Cancer Market Research Report – Global Forecast till 2025. The
report delivers a thorough understanding of the market’s present status and
likely future growth trajectory over the forecast period.
The global prostate
cancer market size was valued at USD 10 billion in 2018 and is expected to
exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025,
according to the latest research report from Market Research Future (MRFR). The
global prostate cancer market is expected to be driven mostly by the growing
awareness about prostate cancer and the increasing entry of effective prostate
cancer medication, according to MRFR.
Segmentation:
The global prostate cancer market
is segmented on the basis of treatment, end user, and region.
By treatment, the global prostate
cancer market is segmented into surgery and medication. The medication segment
is further sub-segmented into chemotherapy, targeted therapy, immunotherapy,
hormone therapy, monoclonal antibodies, and others.
By end use, the global prostate
cancer market is segmented into hospitals and specialty centers.
Regional Analysis:
The Americas is the largest
regional market for prostate cancer, followed by Europe. The widespread
awareness about prostate cancer in North America has been a vital driver for
the global prostate cancer market. According to the American Cancer Society, prostate
cancer is the most common type of cancer among American men, and over 160,000
new cases were registered in 2018. The high geriatric population in North
America and Europe is also a major driver for the global prostate cancer
market.
Prostate Cancer Market – Competitive Landscape
Highly
competitive, the prostate cancer market appears to be fragmented due to the
presence of several notable players. To gain a substantially large competitive
advantage, these players incorporate strategic initiatives such as mergers
& acquisitions, collaboration, expansion, and product launch. Due to the
increasing strategic partnerships, the structure of the market is changing
rapidly. Besides, the growing competition in the market is encouraging
multinational companies to acquire small yet promising companies operating in
the developing markets.
Get Global Prostate Cancer Research Report:
Information by Treatment [Medication (Chemotherapy, Monoclonal Antibodies,
Targeted Therapy, Immunotherapy and Hormone Therapy) and Surgery], End User
(Hospitals & Clinics, Ambulatory Surgical Centres, Specialty Centres,
Others) and Region (the Americas, Europe, Asia-Pacific and the Middle East
& Africa) - Forecast till 2025
Major Players
Players
leading the global prostate cancer market include Bayer Pharma AG (Berlin),
OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US),
OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals
Inc., and Tokai Pharmaceuticals, Inc., among others.
Latest Trending Reports
About US:
Market Research Future
(MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Comments
Post a Comment